Home › Funds › PERCEPTIVE ADVISORS LLC › IMVT

PERCEPTIVE ADVISORS LLC position in IMVT

IMMUNOVANT INC · Health Care

PERCEPTIVE ADVISORS LLC reported holding 1,357,383 shares of IMVT (IMMUNOVANT INC) in its Q2 2026 13F filing — a position valued at US$52.3M, representing 0.83% of its reported portfolio and ranking #28 among its reported holdings. PERCEPTIVE ADVISORS LLC has disclosed IMVT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)1.36M sh
Reported value held$52.30M
Portfolio Weight0.83%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How PERCEPTIVE ADVISORS LLC's IMVT position evolved

PERCEPTIVE ADVISORS LLC first disclosed a stake in IMVT in Q3 2023 at 3,814,691 shares (US$146.4M). Across 12 filings, PERCEPTIVE ADVISORS LLC increased the stake 4 time(s), trimmed it 7 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,357,383 shares valued at US$52.3M — a reduction of -240,000 shares quarter over quarter.. Notable position changes include a 96% trim in Q1 2024 (shares fell 18% over the following quarter), a 100% increase in Q2 2024 (shares rose 8% over the following quarter), a 1089% increase in Q3 2024 (shares fell 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.81M $146.45M New
Q4 2023 2.33M $98.08M Reduce
Q1 2024 100.00K $3.23M Reduce
Q2 2024 200.00K $5.28M Add
Q3 2024 2.38M $67.82M Add
Q4 2024 2.14M $52.99M Reduce
Q1 2025 2.84M $48.61M Add
Q2 2025 2.14M $34.21M Reduce
Q3 2025 1.59M $25.60M Reduce
Q4 2025 1.99M $50.71M Add
Q1 2026 1.60M $39.68M Reduce
Q2 2026 1.36M $52.30M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IMVT and 13F data

IMVT (IMMUNOVANT INC) is a Health Care company. 39 other funds we track also report a position in IMVT — the largest reported positions include Deep Track Capital, LP (US$359.9M), Farallon Capital Management (US$223.7M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$223.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IMVT

All IMVT fund holders →

FAQ

How long has PERCEPTIVE ADVISORS LLC held IMVT?

PERCEPTIVE ADVISORS LLC has disclosed IMVT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is PERCEPTIVE ADVISORS LLC's current position in IMVT?

As of Q2 2026, PERCEPTIVE ADVISORS LLC holds 1.36M shares of IMVT (IMMUNOVANT INC), valued at $52.30M, representing 0.83% of its reported portfolio and ranking #28.

Has PERCEPTIVE ADVISORS LLC been buying or selling IMVT?

In the latest 13F filing (Q2 2026), PERCEPTIVE ADVISORS LLC reduced its position in IMVT.

Which other funds hold IMVT?

Other major institutional holders of IMVT include Deep Track Capital, LP, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.